Reirradiation of primary brain tumours: Survival, clinical response and prognostic factors

Radiotherapy and Oncology

Volumn 59, Issue 2, 2001, Pages 127-137

  Veninga, Theo ^a   Langendijk, Hans A ^b   Slotman, Ben J ^b   Rutten, Ewald H J M ^c   Van Der Kogel, Albert J ^a   Prick, Mathé J J ^d   Keyser, Antoine ^e   Van Der Maazen, Richard W M ^a  

^a Department of Radiation Oncology   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Location Alkmaar   (Netherlands)

^d CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Central nervous system tolerance; Primary brain tumours; Prognostic factors; Quality of life; Reirradiation; Survival

Indexed keywords

CORTICOSTEROID;

ADOLESCENT; ADULT; AGED; ASTROCYTOMA; BIOEQUIVALENCE; BRAIN CANCER; CANCER GROWTH; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; FEMALE; FOLLOW UP; HUMAN; IRRADIATION; MALE; OLIGODENDROGLIOMA; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RADIATION DOSE; RADIATION INJURY; RADIATION RESPONSE; REVIEW; SELF CARE; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; ADULT; BRAIN NEOPLASMS; CRANIAL IRRADIATION; FEMALE; HUMANS; MALE; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; QUALITY OF LIFE; RADIOTHERAPY DOSAGE; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0035336749     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(01)00299-7     Document Type: Review

References (45)

1. Ammirati M., Galicich J.H., Arbit E., Liao Y. Reoperation in the treatment of recurrent intracranial malignant gliomas. Neurosurgery. 21:1987;607-613.
2. Ang K.K., Price R.E., Stephens L.C., et al. The tolerance of primate spinal cord to re-irradiation. Int J Radiat Oncol Biol Phys. 25:1993;459-464.
3. Arcicasa M., Roncadin M., Bidoli E., Dedkov A., Gigante M., Trovò M.G. Reirradiation and lomustine in patients with relapsed high-grade gliomas. Int J Radiat Oncol Biol Phys. 43:1999;789-793.
4. Bauman G.S., Sneed P.K., Wara W.M., et al. Reirradiation of primary CNS tumors. Int J Radiat Oncol Biol Phys. 36:1996;433-441.
5. Burger P.C., Mahaley M.S., Dudka L., Vogel F.S. The morphologic effects of radiation administered therapeutically for intracranial gliomas: a postmortem study of 25 cases. Cancer. 44:1979;1256-1272.
6. Cho K.H., Hall W.A., Gerbi B.J., Higgins P.D., McGuire W.A., Clark H.B. Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas. Int J Radiat Oncol Biol Phys. 45:1999;1133-1141.
7. Cooper J.S., Steinfeld A.D., Lerch I.A. Cerebral metastases: value of reirradiation in selected patients. Radiology. 174:1990;883-885.
8. Cox D.R. Regression models and life tables. J R Stat Soc B. 34:1972;187-220.
9. Curran W.J. Jr, Scott C.B., Horton J., et al. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst. 85:1993;704-710.
10. Daumas-Duport C., Scheithauer B.W., O'Fallon J., Kelly P. Grading of astrocytomas: a simple and reproducible method. Cancer. 62:1988;2152-2165.
11. Fowler J.F. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol. 62:1989;679-694.
12. Harsh G.R. IV, Levin V.A., Gutin P.H., Seager M., Silver P., Wilson C.B. Reoperation for recurrent glioblastoma and anaplastic astrocytoma. Neurosurgery. 21:1987;615-620.
13. Hazuka M.B., Kinzie J.J. Brain metastases: results and effects of re-irradiation. Int J Radiat Oncol Biol Phys. 15:1988;433-437.
14. Hudes R.S., Corn B.W., Werner-Wasik M., et al. A phase I dose escalation study of hypofractionated stereotactic radiotherapy as salvage therapy for persistent or recurrent malignant glioma. Int J Radiat Oncol Biol Phys. 43:1999;293-298.
15. ICRU 50. Prescribing, recording and reporting photon beam therapy. 1993;ICRU, Bethesda, MD.
16. Joiner M.C., Van der Kogel A.J. The linear-quadratic approach to fractionation and calculation of isoeffect relationships. Steel G.G. Basic clinical radiobiology. 2nd ed. 1997;106-122 Arnold, London.
17. Kaplan E.L., Meier P. Non-parametric estimation from incomplete observations. J Am Stat Soc. 53:1958;457-481.
18. Kleihues P., Burger P.C., Scheithauer B.W. The new WHO classification of brain tumours. Brain Pathol. 3:1993;255-268.
19. Leibel S.A., Gutin P.H., Wara W.M., et al. Survival and quality of life after interstitial implantation of removable high-activity iodine-125 sources for the treatment of patients with recurrent malignant gliomas. Int J Radiat Oncol Biol Phys. 17:1989;1129-1139.
20. Levin V.A. Chemotherapy of primary brain tumors. Neurol Clin. 3:1985;855-866.
21. Lutterbach J., Weigel P., Guttenberger R., Hinkelbein W. Accelerated hyperfractionated radiotherapy in 149 patients with glioblastoma multiforme. Radiother Oncol. 53:1999;49-52.
22. Macdonald D.R., Cascino T.L., Clifford Schold S. Jr, Cairncross J.G. Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol. 8:1990;1277-1280.
23. Marks J.E., Baglan R.J., Prassad S.C., Blank W.F. Cerebral radionecrosis: incidence and risk in relation to dose, time, fractionation and volume. Int J Radiat Oncol Biol Phys. 7:1981;243-252.
24. Miller A.B., Hoogstraten B., Staquet M., Winkler A. Reporting results of cancer treatment. Cancer. 47:1981;207-214.
25. Mornex F., Nayel H., Taillandier L. Radiation therapy for malignant astrocytomas in adults. Radiother Oncol. 27:1993;181-191.
26. Oppitz U., Maessen D., Zunterer H., Richter S., Flentje M. 3D-recurrence-patterns of glioblastomas after CT-planned postoperative irradiation. Radiother Oncol. 53:1999;53-57.
27. Peto R., Pike M.C., Armitage P., et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Br J Cancer. 35:1977;1-39.
28. Prados M.D. Treatment strategies for patients with recurrent brain tumors. Semin Radiat Oncol. 1:1991;62-68.
29. Salminen E., Nuutinen J.M., Huhtala S. Multivariate analysis of prognostic factors in 106 patients with malignant glioma. Eur J Cancer. 32A:1996;1918-1923.
30. SAS System for Windows, release 6.12. 1996;SAS Institute, Inc, Cary, NC.
31. Schultheiss T.E., Stephens L.C., Jiang G-L., Ang K.K., Peters L.J. Radiation myelopathy in primates treated with conventional fractionation. Int J Radiat Oncol Biol Phys. 19:1990;935-940.
32. Schultheiss T.E., Kun L.E., Ang K.K., Stephens L.C. Radiation response of the central nervous system. Int J Radiat Oncol Biol Phys. 31:1995;1093-1112.
33. Sheline G.E. Radiation therapy of recurrent gliomas. Semin Oncol. 2:1975;47.
34. Sheline G.E., Wara W.M., Smith V. Therapeutic irradiation and brain injury. Int J Radiat Oncol Biol Phys. 6:1980;1215-1228.
35. Shepherd S.F., Laing R.W., Cosgrove V.P., et al. Hypofractionated stereotactic radiotherapy in the management of recurrent glioma. Int J Radiat Oncol Biol Phys. 37:1997;393-398.
36. Shibamoto Y., Yamashita J., Takahashi M., Abe M. Intraoperative radiation therapy for brain tumors with emphasis on retreatment for recurrence following full-dose external beam irradiation. Am J Clin Oncol. 17:1994;396-399.
37. Silbergeld D.L., Griffin B.R., Ojemann G.A. Reirradiation for recurrent cerebral astrocytoma. J Neurooncol. 12:1992;145-151.
38. Smith M.T., Ludwig C.L., Godfrey A.D., Armbustmacher V.W. Grading of oligodendrogliomas. Cancer. 52:1983;2107-2114.
39. Sneed P.K., Stauffer P.R., Gutin P.H., et al. Interstitial irradiation and hyperthermia for the treatment of recurrent malignant brain tumors. Neurosurgery. 28:1991;206-215.
40. Van der Kogel A.J. Clinical implications of radiobiological studies on CNS tolerance. Karim L. Glioma: principles and practice in neuro-oncology. 1991;179-188 Springer-Verlag, Berlin.
41. Van der Kogel A.J. Radiation response and tolerance of normal tissues. Steel G.G. Basic clinical radiobiology. 2nd ed. 1997;30-39 Arnold, London.
42. Wallner K.E., Galicich J.H., Krol G., Arbit E., Malkin M.G. Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys. 16:1989;1405-1409.
43. Wong W.W., Schild S.E., Sawyer T.E., Shaw E.G. Analysis of outcome in patients reirradiated for brain metastases. Int J Radiat Oncol Biol Phys. 34:1996;585-590.
44. Wood J.R., Green S.B., Shapiro W.R. The prognostic importance of tumor size in malignant gliomas: a computed tomographic scan study by the Brain Tumor Cooperative Group. J Clin Oncol. 6:1988;338-343.
45. Young B., Oldfield E.H., Markesbery W.R., et al. Reoperation for glioblastoma. J Neurosurg. 55:1981;917-921.